REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026TRENDINGHexarelin: ↑↑ Surging ��� Trends score 100 as of May 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingEVENTpep-talk con ��� First US Peptide Convention · August 2026 · Anaheim CAFDAFDA advisory committee meetings scheduled: late July 2026

For research purposes only. Full disclaimer →

Research Library

749 papers · 61 analysis articles

Research Analysis

Curated deep-dives into the latest peptide research

Papers Database

Effect of thymosin α1 on Immune response and organ function in acute aortic dissection surgery: PANDA II trial protocol.

Liu Hong et al.Future cardiology2025
pubmedClinical Trial

Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.

Aronne Louis J et al.The New England journal of medicine2025
pubmedClinical Trial

Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics.

Nicholls Stephen J et al.American heart journal2024
pubmedClinical Trial

Effect of Semaglutide on Physical Function, Body Composition, and Biomarkers of Aging in Older Adults With Overweight and Insulin Resistance: Protocol for an Open-Labeled Randomized Controlled Trial.

Cortes Tiffany M et al.JMIR research protocols2024
pubmedClinical Trial

Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial.

Pant Shubham et al.Nature medicine2024
pubmedClinical Trial

Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial.

Gonzales Mitzi M et al.Nature medicine2023
pubmedClinical Trial

A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses.

Smith Katherine E R et al.Frontiers in immunology2023
pubmedClinical Trial

Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma.

Löffler Markus W et al.Clinical cancer research : an official journal of the American Association for Cancer Research2022
pubmedClinical Trial

Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity.

Leung Daniel et al.Frontiers in immunology2022
pubmedClinical Trial

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.

Del Prato Stefano et al.Lancet (London, England)2021
pubmedClinical Trial

Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.

Brudno Jennifer N et al.Nature medicine2020
pubmedClinical Trial

[The efficacy of semax in the tretament of patients at different stages of ischemic stroke].

Gusev E I et al.Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova2018
pubmedClinical Trial

Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.

M. Ionescu et al.The Journal of clinical endocrinology and metabolism2006
S2Clinical Trial

Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children.

G. Guzzaloni et al.Minerva endocrinologica1998
S2Clinical Trial